Senestech (SNES) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual Meeting scheduled for June 9, 2026, to address director elections, executive compensation, equity plan amendment, and auditor ratification.
Record date for voting is April 20, 2026, with 5,265,744 shares outstanding and approximately 687 stockholders of record.
Proxy materials are primarily distributed electronically to reduce costs, with paper copies available upon request.
Voting matters and shareholder proposals
Election of two Class I directors (Jake S. Leach and Joshua M. Moss) for three-year terms expiring in 2029.
Advisory (non-binding) vote on executive compensation for fiscal 2025 (say-on-pay).
Approval sought for an amendment to the 2018 Equity Incentive Plan to add 1,700,000 shares.
Ratification of M & K CPAS, PLLC as independent auditor for fiscal year ending December 31, 2026.
Shareholder proposals for the 2027 meeting must be received by December 30, 2026, for inclusion.
Board of directors and corporate governance
Board consists of seven directors divided into three classes, with staggered three-year terms.
Majority of directors are independent per Nasdaq standards; separation of CEO and Chair roles.
Standing committees: audit, compensation, nominating and corporate governance, and commercialization.
Board emphasizes diversity, independence, and relevant expertise in director nominations.
Code of Business Conduct and Ethics and insider trading policy in place.
Latest events from Senestech
- New CEO and Board Chair appointed; equity plan amendments and option grants up for shareholder vote.SNES
Proxy filing7 May 2026 - Key votes include director elections, equity plan expansion, and auditor ratification.SNES
Proxy filing29 Apr 2026 - E-commerce drove 20% revenue growth, margin gains, and cash runway extends to Q2 2027.SNES
Q4 202512 Mar 2026 - Record revenue and margin gains, but cash constraints require new financing for profitability.SNES
Q2 20241 Feb 2026 - Record growth fueled by innovative fertility control products and expanding global distribution.SNES
Lytham Partners Fall 2024 Investor Conference20 Jan 2026 - Record Q3 revenue and margin gains fueled by Evolve products and e-commerce growth.SNES
Q3 202414 Jan 2026 - Evolve products now drive 70% of sales, fueling rapid growth and improved profitability.SNES
Lytham Partners 2025 Industrials & Basic Materials Investor Summit26 Dec 2025 - Record 70% revenue growth and 61% margin drive progress toward profitability.SNES
Q4 202424 Dec 2025 - Resale of 1.5M+ shares from warrant exercises funds humane rodent control, but financial risk remains.SNES
Registration Filing16 Dec 2025